ABUS
Price:
$3.51
Market Cap:
$665.12M
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated N-acetylgalactosamine (GalNAc) delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication. The company's research and development programs include AB-161, an oral HBV RNA destabilizer to destab...[Read more]
Industry
Biotechnology
IPO Date
2007-07-26
Stock Exchange
NASDAQ
Ticker
ABUS
According to Arbutus Biopharma Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 7.02. This represents a change of 7.36% compared to the average of 6.54 of the last 4 quarters.
The mean historical Current Ratio of Arbutus Biopharma Corporation over the last ten years is 11.19. The current 7.02 Current Ratio has changed 6.17% with respect to the historical average. Over the past ten years (40 quarters), ABUS's Current Ratio was at its highest in in the March 2020 quarter at 21.91. The Current Ratio was at its lowest in in the December 2022 quarter at 4.60.
Average
11.19
Median
12.25
Minimum
4.60
Maximum
17.38
Discovering the peaks and valleys of Arbutus Biopharma Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 115.05%
Maximum Annual Current Ratio = 17.38
Minimum Annual Increase = -67.87%
Minimum Annual Current Ratio = 4.60
Year | Current Ratio | Change |
---|---|---|
2023 | 5.87 | 27.64% |
2022 | 4.60 | -67.87% |
2021 | 14.32 | 6.97% |
2020 | 13.38 | 11.67% |
2019 | 11.99 | -7.23% |
2018 | 12.92 | 18.82% |
2017 | 10.87 | -13.07% |
2016 | 12.51 | -28.04% |
2015 | 17.38 | 115.05% |
2014 | 8.08 | 43.90% |
The current Current Ratio of Arbutus Biopharma Corporation (ABUS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.26
5-year avg
10.03
10-year avg
11.19
Arbutus Biopharma Corporation’s Current Ratio is greater than VBI Vaccines Inc. (0.34), less than ADMA Biologics, Inc. (7.09), greater than Adaptimmune Therapeutics plc (3.85), greater than Affimed N.V. (1.93), greater than Corvus Pharmaceuticals, Inc. (0.92),
Company | Current Ratio | Market cap |
---|---|---|
0.34 | $1.87M | |
7.09 | $5.01B | |
3.85 | $176.64M | |
1.93 | $39.90M | |
0.92 | $575.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arbutus Biopharma Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arbutus Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Arbutus Biopharma Corporation's Current Ratio?
How is the Current Ratio calculated for Arbutus Biopharma Corporation (ABUS)?
What is the highest Current Ratio for Arbutus Biopharma Corporation (ABUS)?
What is the 3-year average Current Ratio for Arbutus Biopharma Corporation (ABUS)?
What is the 5-year average Current Ratio for Arbutus Biopharma Corporation (ABUS)?
How does the current Current Ratio for Arbutus Biopharma Corporation (ABUS) compare to its historical average?